Title: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes
PDB DOI: https://doi.org/10.2210/pdb3g8i/pdb
Primary publication DOI: https://doi.org/10.1016/j.bmcl.2009.03.036
Entry authors: Benz, J., Bernardeau, A., Binggeli, A., Blum, D., Boehringer, M., Grether, U., Hilpert, H., Kuhn, B., Maerki, H.P., Meyer, M., Puentener, K., Raab, S., Ruf, A., Schlatter, D., Gsell, B., Stihle, M., Mohr, P.
Initial deposition on: 12 February 2009
Initial release on: 2 June 2009
Latest revision on: 1 November 2023
Structure coordinates (PDBx/mmCIF)
X-ray diffraction data (PDBx/mmCIF)